WalderB., RobinX., RebetezM.M., CopinJ.C., GascheY., SanchezJ.C., and TurckN. (2013). The prognostic significance of the serum biomarker H-FABP in comparison with S100b in severe traumatic brain injury. J. Neurotrauma, 30, 1631–1637.
2.
WunderlichM.T., HanhoffT., GoertlerM., SpenereF., GlatzJ.F., WalleschC.W., and PelsersM.M. (2005). Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke. J Neurol, 252, 718–724.
3.
PelsersM.M., HanhoffT., van der VoortD., ArtsB., PetersM., PondsR., HonigA., RudzinskiW., SpenerF., de KruijkJ.R., TwijnstraA., HermensW.T., MenheereP.P., and GlatzJ.F. (2004). Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility. Clin. Chem., 50, 1568–1575.
4.
VervlietB.H., HulscherJ.B., ten DuisH.J., WilczakN., and van der NaaltJ. (2012). The diagnostic value of brain fatty acid binding protein in traumatic brain injury. Poster presentation at the International Brain Injury Association 9th World Congress, Edinburgh.
5.
PelsersM.M., and GlatzJ.F. (2005). Detection of brain injury by fatty acid-binding proteins. Clin. Chem. Lab. Med., 43, 802–809.
